Catalyst Wire Dossier Catalyst Wire Dossier

CAMCEVI

leuprolide · Accord BioPharma, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CAMCEVI, covering 2021-05-25 to 2026-02-11. Get the full timeline:

Most recent: FDA Approved: CAMCEVI — Supplemental Application (Accord BioPharma, Inc.)

See pricing